Patent ID: 8486125

Claim:
A method comprising: generating a first soliton wave through a laser diode of a first medical instrument at a wavelength of approximately 660 nm to 808 nm; generating a second soliton wave through a laser diode of a second medical instrument at a wavelength of approximately 660 nm to 808 nm; applying the first soliton wave to a first application point located over the left kidney of a patient suffering from Type I or Type II diabetes on the small of the patient's back, one hand width above the belt and one hand width to the left of the spine, for a one minute duration; repeating the application of the first soliton wave to the first application point for the one minute duration two more times in the same day; applying the second soliton wave to a second application point located over the extreme outer edge of the patient's inner elbow crease, for a one minute duration; repeating the application of the second soliton wave to the second application point for the one minute duration two more times in the same day; coordinating the application of the first soliton wave and the second soliton wave through an algorithm that controls the generation of the first soliton wave of the first medical instrument and the generation of the second soliton wave of the second medical instrument; and reducing a glycosylated hemoglobin Alc (HbAlc) of the patient as a result of the application of the first soliton wave and the second soliton wave.